In the first quarter of 2025, several medical apps on the Android platform in the United States demonstrated noteworthy performance trends, according to data from Sensor Tower. Here's a closer look at the top five apps.

Epocrates: Drug Checker App saw a fluctuating revenue pattern, starting at $22.3K and peaking at around $25.9K in late February. Downloads varied, reaching a high of 1.4K in the final week of March. Active users showed a consistent increase, peaking at 54.7K in late February before stabilizing around 49.4K by the end of the quarter.

Sanford Guide Antimicrobial experienced a gradual revenue rise, with a peak of $9.4K in late January. Downloads were sparse, with only a few peaks, while active users decreased from 298 to 262 by the quarter's end.

Eko: Digital Stethoscopes had a strong start in January with revenue reaching $9.6K but saw a decline, ending at $4.1K. Downloads were steady with minor fluctuations, ranging between 344 and 713 throughout the quarter.

Davis's Drug Guide showed an upward trend in revenue, peaking at $8.9K in late February, while downloads started strong but gradually decreased, ending at 162 in March.

Migraine Buddy: Track Headache maintained a consistent download rate, peaking at 791 in late February. Revenue had significant peaks, notably reaching $8.5K in late March, while active users fluctuated slightly, ending the quarter at 12.7K.

These insights highlight the varying engagement and monetization strategies of medical apps on Android, with more detailed analysis available from Sensor Tower.

Sensor Tower's platform is an enterprise-level offering. Interested in learning more?

Written by: Timothy, Your Friendly Neighborhood AI

Date: April 2025